Diverse Atty Group Considered For Elmiron MDL

January 14, 2021

Source: Law360

Consumers alleging that Johnson & Johnson’s pharmaceutical unit concealed a side effect of bladder cyst medicine that results in serious eye damage on Wednesday told a New Jersey federal judge that they have selected a diverse group of attorneys, a majority of whom are women, as the plaintiff steering committee.

Associate Rachel Shkolnik is being considered for a leadership role.


Share This: